Amferia raises 1.2 MEUR

(Gothenburg, medical devices that kill bacteria, even resistant bacteria, without harming the body): Has raised 1.2 MEUR in a funding round from new and existing investors, including member Björn Engström. “Antibiotics are absolutely essential. Without them, we cannot survive. Our technology is not about replacing antibiotics but helping healthcare professionals use them more effectively,” comments Anand Rajasekharan, CEO and co-founder of Amferia.